Featured image of the article Q4 2025 RF Front-End IP: Stable Leaders, China Accelerates, Lansus Enters Top Five, Filters Dominate.

Q4 2025 RF Front-End IP: Stable Leaders, China Accelerates, Lansus Enters Top Five, Filters Dominate

SOPHIA ANTIPOLIS, France – January 26, 2025 │ KnowMade’s Q4 2025 RF Front-End Modules & Components Patent Monitor confirms that RF front-end innovation remains structurally stable while becoming increasingly competitive. The quarter covers 611 new patent families, 477 newly granted families, and 226 expired or abandoned patents, reflecting a robust global IP pipeline across both[…]

Featured image of the article Co-Packaged Optics and Optical Interconnects: A Global Picture of the IP Competition.

Co-packaged Optics and Optical Interconnects: A Global Picture of the IP Competition

SOPHIA ANTIPOLIS, France – January 21, 2026 │ KnowMade, a leading provider of patent analysis services, is proud to announce the release of its latest report, Co-Packaged Optics and Optical Interconnects Patent Landscape Analysis. This comprehensive report provides a detailed examination of the competitive landscape of the co-packaged optics (CPO) and optical interconnects (I/O) technology[…]

Featured image of the article Silicon Anode Li-ion Batteries: Intensifying Innovation and Expanding Patent Activity in Q4 2025.

Silicon Anode Li-ion Batteries: Intensifying Innovation and Expanding Patent Activity in Q4 2025

SOPHIA ANTIPOLIS, France – January 20, 2026 │As worldwide R&D efforts in Li-ion batteries continue to intensify, silicon anode technology has become one of the major focuses of innovation. KnowMade’s Patent Monitoring Service for Silicon Anode Li-ion Batteries enables you to stay ahead by closely following the latest technological advances and the key entities shaping[…]

Featured image of the article Continued Innovation in mRNA Technology: Key Trends from Q4 2024 Patent Monitor.

Therapeutic mRNA Innovation: 200 New Patent Applications and 125 Granted Patents in Q4 2025

SOPHIA ANTIPOLIS, France – January 19, 2026 │ The mRNA therapeutics landscape maintained strong momentum in Q4 2025 with 200 new patent applications and a record 125 granted patents across key jurisdictions (US, EP, JP, KR). This quarter highlights the expanding global reach of RNA-based technologies and shifts in strategic IP positioning. Therapeutic mRNA patent[…]